SARS-CoV-2 seroprevalence in COVID-19 hotspots
Lancet
.
2020 Aug 22;396(10250):514-515.
doi: 10.1016/S0140-6736(20)31482-3.
Epub 2020 Jul 6.
Authors
Isabella Eckerle
1
,
Benjamin Meyer
2
Affiliations
1
Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland. Electronic address: isabella.eckerle@hcuge.ch.
2
Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
PMID:
32645348
PMCID:
PMC7336129
DOI:
10.1016/S0140-6736(20)31482-3
No abstract available
Publication types
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
Prevalence
SARS-CoV-2
Seroepidemiologic Studies
Spain